← Evidence map

ArticleBiochemistry and biophysics reports2025

Corrigendum to "PAK4 inhibition significantly potentiates gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways" [Biochemistry and Biophysics Reports, (35), September 2023, 1-8 / 101544].

Charudatt Samant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "PAK4 inhibition significantly potentiates gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways" [Biochemistry and Biophysics Reports, (35), September 2023, 1-8 / 101544]. | OpenQuestion